JP2004522798A5 - - Google Patents

Download PDF

Info

Publication number
JP2004522798A5
JP2004522798A5 JP2002571033A JP2002571033A JP2004522798A5 JP 2004522798 A5 JP2004522798 A5 JP 2004522798A5 JP 2002571033 A JP2002571033 A JP 2002571033A JP 2002571033 A JP2002571033 A JP 2002571033A JP 2004522798 A5 JP2004522798 A5 JP 2004522798A5
Authority
JP
Japan
Prior art keywords
metoprolol
liquid medium
microparticles
weight
particle size
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002571033A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004522798A (ja
Filing date
Publication date
Priority claimed from SE0100824A external-priority patent/SE0100824D0/xx
Application filed filed Critical
Publication of JP2004522798A publication Critical patent/JP2004522798A/ja
Publication of JP2004522798A5 publication Critical patent/JP2004522798A5/ja
Pending legal-status Critical Current

Links

JP2002571033A 2001-03-09 2002-03-06 メトプロロールを含有する微粒子を製造する方法 Pending JP2004522798A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0100824A SE0100824D0 (sv) 2001-03-09 2001-03-09 Method III to obtain microparticles
PCT/SE2002/000401 WO2002072074A1 (en) 2001-03-09 2002-03-06 Method to prepare microparticles metoprolol that contain

Publications (2)

Publication Number Publication Date
JP2004522798A JP2004522798A (ja) 2004-07-29
JP2004522798A5 true JP2004522798A5 (enExample) 2005-12-22

Family

ID=20283295

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002571033A Pending JP2004522798A (ja) 2001-03-09 2002-03-06 メトプロロールを含有する微粒子を製造する方法

Country Status (24)

Country Link
US (1) US20040116392A1 (enExample)
EP (1) EP1370245B1 (enExample)
JP (1) JP2004522798A (enExample)
KR (1) KR20030081507A (enExample)
CN (1) CN1236761C (enExample)
AT (1) ATE295153T1 (enExample)
AU (1) AU2002235102B2 (enExample)
BR (1) BR0207919A (enExample)
CA (1) CA2440167A1 (enExample)
DE (1) DE60204125T2 (enExample)
ES (1) ES2240691T3 (enExample)
HU (1) HUP0303450A2 (enExample)
IL (1) IL157777A0 (enExample)
IS (1) IS6937A (enExample)
MX (1) MXPA03008088A (enExample)
NO (1) NO20033967L (enExample)
NZ (1) NZ528168A (enExample)
PL (1) PL363972A1 (enExample)
PT (1) PT1370245E (enExample)
RU (1) RU2292878C2 (enExample)
SE (1) SE0100824D0 (enExample)
UA (1) UA75909C2 (enExample)
WO (1) WO2002072074A1 (enExample)
ZA (1) ZA200306880B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0100823D0 (sv) * 2001-03-09 2001-03-09 Astrazeneca Ab Method I to obtain microparticles
US20060159756A1 (en) * 1999-09-10 2006-07-20 Brita Sjoblom Method to obtain microparticles containing an H+,K+-ATP-ASE inhibitor
SE0100822D0 (sv) * 2001-03-09 2001-03-09 Astrazeneca Ab Method II to obtain microparticles
US8006685B2 (en) * 2002-07-05 2011-08-30 Turbochef Technologies, Inc. Re-circulating oven with gas clean-up
EP1915137B8 (de) 2005-08-10 2013-09-11 ADD Advanced Drug Delivery Technologies, Ltd. Orales präparat mit kontrollierter freisetzung
US20070053983A1 (en) * 2005-09-06 2007-03-08 Girish Jain Extended release compositions of metoprolol succinate
NZ574427A (en) * 2006-07-28 2011-11-25 Zaklady Farmaceutyczne Polpharma S A Extended release pharmaceutical formulation of metoprolol and process for its preparation
ES2753148T3 (es) * 2007-02-23 2020-04-07 Glatt Air Techniques Inc Método para determinar el peso del recubrimiento que va a ser aplicado para formar una forma de dosificación de liberación controlada
CN101269056B (zh) * 2007-03-19 2010-05-19 天津药物研究院 一种美托洛尔盐类口服脉冲微丸制剂
NZ584521A (en) * 2007-10-10 2011-03-31 Avantor Performance Mat Inc Directly compressible high functionality granular microcrystalline cellulose based excipient, manufacturing process and use thereof
US20100055180A1 (en) * 2007-10-10 2010-03-04 Mallinckrodt Baker, Inc. Directly Compressible Granular Microcrystalline Cellulose Based Excipient, Manufacturing Process and Use Thereof
CN102641257A (zh) * 2012-03-31 2012-08-22 内蒙古医学院 阿替洛尔缓释微囊及其制备方法
RU2585023C1 (ru) * 2014-12-18 2016-05-27 Общество с ограниченной ответственностью "Нанолек" Способ гранулирования
CN104739805B (zh) * 2015-04-09 2017-12-19 邸蓉 制备琥珀酸美托洛尔缓释微丸的复相乳液法
WO2019183470A2 (en) 2018-03-22 2019-09-26 Incarda Therapeutics, Inc. A novel method to slow ventricular rate
CN115252913A (zh) * 2022-08-02 2022-11-01 赛诺神畅医疗科技有限公司 一种血管给药涂层及其制备方法和应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US653014A (en) * 1899-10-06 1900-07-03 Ashley & Bailey Company Process of silkifying cotton.
SE354851B (enExample) * 1970-02-18 1973-03-26 Haessle Ab
SE418247B (sv) * 1975-11-17 1981-05-18 Haessle Ab Sett att framstella kroppar med reglerad frigoring av en aktiv komponent
DE3565475D1 (en) * 1984-04-07 1988-11-17 Bayer Ag Process and apparatus for the production of granules
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
SE450087B (sv) * 1985-10-11 1987-06-09 Haessle Ab Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial
SE455836B (sv) * 1985-10-11 1988-08-15 Haessle Ab Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning
DE3909455A1 (de) * 1989-03-22 1990-09-27 Hoechst Ag Verfahren zur herstellung von wasserdispergierbaren granulaten
FR2725623A1 (fr) * 1994-10-18 1996-04-19 Flamel Tech Sa Microcapsules medicamenteuses et/ou nutritionnelles pour administration per os
AU6824996A (en) * 1995-08-17 1997-03-12 Dyer, Alison Margaret Controlled release products
DE19613395A1 (de) * 1996-04-03 1997-10-09 Basf Ag Granulate hygroskopischer, wasserlöslicher Produkte
US6096339A (en) * 1997-04-04 2000-08-01 Alza Corporation Dosage form, process of making and using same
US5891474A (en) * 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
DE19733094A1 (de) * 1997-07-31 1999-02-04 Merck Patent Gmbh Formulierung auf der Basis von Ascorbinsäure mit verbesserter Farbstabilität
WO1999018935A1 (de) * 1997-10-15 1999-04-22 Merck Patent Gmbh Herstellung eines direkt verpressbaren tablettierhilfsstoffes
EP0987020A1 (en) * 1998-09-04 2000-03-22 Pharma Pass LLC Metoprolol composition and processes for manufacturing the same
US6395300B1 (en) * 1999-05-27 2002-05-28 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
US20060159756A1 (en) * 1999-09-10 2006-07-20 Brita Sjoblom Method to obtain microparticles containing an H+,K+-ATP-ASE inhibitor
SE0100823D0 (sv) * 2001-03-09 2001-03-09 Astrazeneca Ab Method I to obtain microparticles
TWI354568B (en) * 2000-09-20 2011-12-21 Jagotec Ag Insoluble drug particle compositions with improved
SE0100822D0 (sv) * 2001-03-09 2001-03-09 Astrazeneca Ab Method II to obtain microparticles

Similar Documents

Publication Publication Date Title
JP2004522798A5 (enExample)
Watano et al. Fine particle coating by a novel rotating fluidized bed coater
JP3447042B2 (ja) 単一物質球形粒の製造方法
Agnihotri et al. Microencapsulation–a novel approach in drug delivery: a review
Rodriguez et al. Description and preliminary evaluation of a new ultrasonic atomizer for spray-congealing processes
EP0058765B1 (de) In Magensaft lösliche oder quellbare Überzugsmasse und ihre Verwendung in einem Verfahren zum Überziehen von Arzneiformen
Khandbahale Microencapsulation-A novel approach in drug delivery: A review
JP2004522796A5 (enExample)
AU2113795A (en) Apparatus and method for preparing solid forms with controlled release of the active ingredient
Phutane et al. In vitro evaluation of novel sustained release microspheres of glipizide prepared by the emulsion solvent diffusion-evaporation method
Kondo et al. Design of sustained release fine particles using two-step mechanical powder processing: particle shape modification of drug crystals and dry particle coating with polymer nanoparticle agglomerate
Gu et al. Wet Spheronization by Rotary Processing—A Multistage Single‐Pot Process for Producing Spheroids
DE60204125T2 (de) Verfahren zur herstellung von metoprolol enthaltenden mikropartikeln
WO2005000312A8 (ja) 薬物徐放性粒子及びその製法
Kondo et al. Mechanical particle coating using ethylcellulose nanoparticle agglomerates for preparing controlled release fine particles; effect of coating temperature on coating performance
WO1997003656A1 (fr) Preparation granulaire et son procede de production
JP2012087073A (ja) コーティング粒子の製造方法、及び該製造方法で製造されたコーティング粒子
Ichikawa et al. Microagglomeration of pulverized pharmaceutical powders using the Wurster process I.: Preparation of highly drug-incorporated, subsieve-sized core particles for subsequent microencapsulation by film-coating
JP2022528570A (ja) 有効成分顆粒の連続製造のためのプロセス
EP2023903B1 (en) Process for the preparation and surface coating of pellets
Pisek et al. Influence of Rotational Speed and Surface of Rotating Disc on Pellets Produced by Direct Rotor Peptization
Verma et al. Tablet granulation: current scenario and recent advances
JP2003001091A (ja) 流動層造粒・コーティング方法
Sedighikamal et al. Sustained release coating of ibuprofen pellets at Wurster fluidization: statistical approach
US5160469A (en) Manufacture of pellets of xanthine derivatives